Skip to main content
Erschienen in: AIDS and Behavior 5/2006

01.09.2006

The Role of HIV Serostatus Disclosure in Antiretroviral Medication Adherence

verfasst von: Michael J. Stirratt, Robert H. Remien, Anna Smith, Olivia Q. Copeland, Curtis Dolezal, Daniel Krieger, the SMART Couples Study Team

Erschienen in: AIDS and Behavior | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

This study examined the relationship between HIV serostatus disclosure and adherence to antiretroviral therapy (ART). The study was conducted with 215 HIV-seropositive patients who demonstrated poor adherence (<80%) and who were in serodiscordant relationships. Participants completed self-report measures regarding HIV serostatus disclosure and reasons for missing ART doses, as well as electronic monitoring of ART adherence (MEMS caps). Overall, 19% of the sample reported missing medication doses in the last two months due to concerns regarding serostatus disclosure. Participants who reported greater serostatus disclosure to others demonstrated higher rates of adherence, and this relationship remained after controlling for other explanatory variables. The relationship between disclosure and adherence was not mediated by practical support for adherence from others. Interventions to improve ART adherence should address the role of serostatus disclosure by providing patients with skills to maintain adherence in contexts of non-disclosure and to make informed choices regarding selective disclosure.
Literatur
Zurück zum Zitat Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., et al. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndrome, 31, S123–S127. Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., et al. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndrome, 31, S123–S127.
Zurück zum Zitat Bangsberg, D. R., Hecht, F. M., Charlebois, E., Zolopa, A. R., Holodiny, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357–366.CrossRefPubMed Bangsberg, D. R., Hecht, F. M., Charlebois, E., Zolopa, A. R., Holodiny, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357–366.CrossRefPubMed
Zurück zum Zitat Bangsberg, D. R., Sharon, P., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., et al. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15, 1181–1183.CrossRefPubMed Bangsberg, D. R., Sharon, P., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., et al. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15, 1181–1183.CrossRefPubMed
Zurück zum Zitat Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51, 1173–1182.CrossRefPubMed Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51, 1173–1182.CrossRefPubMed
Zurück zum Zitat Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the beck depression inventory-II. San Antonio, TX: Psychological Corporation. Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the beck depression inventory-II. San Antonio, TX: Psychological Corporation.
Zurück zum Zitat Black, B. P., & Miles, M. S. (2002).Calculating the risks and benefits of disclosure in African American women who have HIV. Journal of Obstetric and Gynecological Neonatal Nursing, 31, 688–697. Black, B. P., & Miles, M. S. (2002).Calculating the risks and benefits of disclosure in African American women who have HIV. Journal of Obstetric and Gynecological Neonatal Nursing, 31, 688–697.
Zurück zum Zitat Blaney, N. T., Fernandez, I., Ethier, K. A., Wilson, T. E., Walter, E., & Koenig, L. J., for the Perinatal Guidelines Evaluation Project Group. (2004). Psychosocial and behavioral correlates of depression among HIV-infected pregnant women. AIDS Patient Care and STDs, 18(7), 405–415.CrossRefPubMed Blaney, N. T., Fernandez, I., Ethier, K. A., Wilson, T. E., Walter, E., & Koenig, L. J., for the Perinatal Guidelines Evaluation Project Group. (2004). Psychosocial and behavioral correlates of depression among HIV-infected pregnant women. AIDS Patient Care and STDs, 18(7), 405–415.CrossRefPubMed
Zurück zum Zitat Bozzette, S. A., Berry, S. H., Duan, N., Frankel, M. R., Leibowitz, A. A., Lefkowitz, D., et al. (1998). The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. New England Journal of Medicine, 339(26), 1897–904.PubMedCrossRef Bozzette, S. A., Berry, S. H., Duan, N., Frankel, M. R., Leibowitz, A. A., Lefkowitz, D., et al. (1998). The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. New England Journal of Medicine, 339(26), 1897–904.PubMedCrossRef
Zurück zum Zitat Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAiliffe, T. L. (2000). Patterns, correlates and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124–133.CrossRefPubMed Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAiliffe, T. L. (2000). Patterns, correlates and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124–133.CrossRefPubMed
Zurück zum Zitat Chesney, M. A., Chambers, D. B., Taylor, J. M., & Johnson, L. M. (2003). Social support, distress, and well-being in older men living with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 33, S185 –S193.PubMed Chesney, M. A., Chambers, D. B., Taylor, J. M., & Johnson, L. M. (2003). Social support, distress, and well-being in older men living with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 33, S185 –S193.PubMed
Zurück zum Zitat Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee and Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255–266.CrossRefPubMed Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee and Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255–266.CrossRefPubMed
Zurück zum Zitat Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., & Rabkin, J. (1999). Adherence: a necessity for successful HIV combination therapy. AIDS, 12(Supp A), S271–S278. Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., & Rabkin, J. (1999). Adherence: a necessity for successful HIV combination therapy. AIDS, 12(Supp A), S271–S278.
Zurück zum Zitat Chesney, M. A., & Smith, A. W. (1999). Critical delays in HIV testing and care. American Behavioral Scientist, 42, 1162–1174.CrossRef Chesney, M. A., & Smith, A. W. (1999). Critical delays in HIV testing and care. American Behavioral Scientist, 42, 1162–1174.CrossRef
Zurück zum Zitat Christensen, A., & Shenk, J. L. (1991). Communication, conflict, and psychological distance in nondistressed, clinic, and divorcing couples. Journal of Consulting and Clinical Psychology, 59, 458–463.CrossRefPubMed Christensen, A., & Shenk, J. L. (1991). Communication, conflict, and psychological distance in nondistressed, clinic, and divorcing couples. Journal of Consulting and Clinical Psychology, 59, 458–463.CrossRefPubMed
Zurück zum Zitat Clark, H. J., Lindner, G., Armistead, L., & Austin, B. (2003). Stigma, disclosure, and psychological functioning among HIV-infected and non-infected African-American women. Women and Health, 38(4), 57–71.CrossRef Clark, H. J., Lindner, G., Armistead, L., & Austin, B. (2003). Stigma, disclosure, and psychological functioning among HIV-infected and non-infected African-American women. Women and Health, 38(4), 57–71.CrossRef
Zurück zum Zitat Clingerman, E. (2004). Physical activity, social support, and health-related quality of life among persons with HIV disease. Journal of Community Health Nursing, 21(3), 179–197.CrossRefPubMed Clingerman, E. (2004). Physical activity, social support, and health-related quality of life among persons with HIV disease. Journal of Community Health Nursing, 21(3), 179–197.CrossRefPubMed
Zurück zum Zitat Cohen, C. I., & Sokolovsky, J. (1978). General Social Survey network items. Connections, 8, 119–122. Cohen, C. I., & Sokolovsky, J. (1978). General Social Survey network items. Connections, 8, 119–122.
Zurück zum Zitat D’Angelo, L. J., Abdalian, S. E., Sarr, M., Hoffman, N., Belzer, M., & the Adolescent Medicine HIV/AIDS Research Network. (2001). Disclosure of serostatus by HIV infected youth: The experience of the REACH study (Reaching for Excellence in Adolescent Care and Health). Journal of Adolescent Health, 29, 72–79.CrossRefPubMed D’Angelo, L. J., Abdalian, S. E., Sarr, M., Hoffman, N., Belzer, M., & the Adolescent Medicine HIV/AIDS Research Network. (2001). Disclosure of serostatus by HIV infected youth: The experience of the REACH study (Reaching for Excellence in Adolescent Care and Health). Journal of Adolescent Health, 29, 72–79.CrossRefPubMed
Zurück zum Zitat Demas, P., Schoenbaum, E. E., Wills, T. A., Doll, L. S., & Klein, R. S. (1995). Stress, coping, and attitudes toward HIV treatment in injecting drug users: A qualitative study. AIDS Education and Prevention, 7(5), 429–442.PubMed Demas, P., Schoenbaum, E. E., Wills, T. A., Doll, L. S., & Klein, R. S. (1995). Stress, coping, and attitudes toward HIV treatment in injecting drug users: A qualitative study. AIDS Education and Prevention, 7(5), 429–442.PubMed
Zurück zum Zitat DiMatteo, M. R. (2004). Social support and patient adherence to medical treatment: A meta-analysis. Health Psychology, 23, 207–218.CrossRefPubMed DiMatteo, M. R. (2004). Social support and patient adherence to medical treatment: A meta-analysis. Health Psychology, 23, 207–218.CrossRefPubMed
Zurück zum Zitat Duran, S., Spire, B., Raffi, F., Walter, V., Bouhour, D., Journot, V., et al. (2001). Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clinical Trials, 2(1), 38–45.CrossRefPubMed Duran, S., Spire, B., Raffi, F., Walter, V., Bouhour, D., Journot, V., et al. (2001). Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clinical Trials, 2(1), 38–45.CrossRefPubMed
Zurück zum Zitat El-Bassel, N., Cooper, D. K., Chen, D. R., & Schilling, R. F. (1998). Personal social networks and HIV status among women on methadone. AIDS Care, 10(6), 735–749.CrossRefPubMed El-Bassel, N., Cooper, D. K., Chen, D. R., & Schilling, R. F. (1998). Personal social networks and HIV status among women on methadone. AIDS Care, 10(6), 735–749.CrossRefPubMed
Zurück zum Zitat Ewart, C. K. (1991). Social action theory for a public health psychology. American Psychologist, 46, 931–946.CrossRefPubMed Ewart, C. K. (1991). Social action theory for a public health psychology. American Psychologist, 46, 931–946.CrossRefPubMed
Zurück zum Zitat Gibb, D. M., Goodall, R. L., Giacomet, V., McGee, L., Compagnucci, A., & Lyall, H,, for the Paediatric European Network for Treatment of AIDS Steering Committee (2003). Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatric Infectious Disease Journal, 22, 56–62.CrossRefPubMed Gibb, D. M., Goodall, R. L., Giacomet, V., McGee, L., Compagnucci, A., & Lyall, H,, for the Paediatric European Network for Treatment of AIDS Steering Committee (2003). Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatric Infectious Disease Journal, 22, 56–62.CrossRefPubMed
Zurück zum Zitat Golin, C., Isasi, F., Bontempi, J. B., & Eng, E. (2002). Secret pills: HIV-positive patients’ experiences taking antiretroviral therapy in North Carolina. AIDS Education and Prevention, 14(4), 318–329.CrossRefPubMed Golin, C., Isasi, F., Bontempi, J. B., & Eng, E. (2002). Secret pills: HIV-positive patients’ experiences taking antiretroviral therapy in North Carolina. AIDS Education and Prevention, 14(4), 318–329.CrossRefPubMed
Zurück zum Zitat Gonzalez, J. S., Penedo, F. J., Antoni, M. H., Duran, R. E., Fernandez, M. I., McPherson-Baker, S., et al. (2004). Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychology, 23, 413–418.CrossRefPubMed Gonzalez, J. S., Penedo, F. J., Antoni, M. H., Duran, R. E., Fernandez, M. I., McPherson-Baker, S., et al. (2004). Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychology, 23, 413–418.CrossRefPubMed
Zurück zum Zitat Gordillo, V., del Amo, J., Soriano, V., & Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763–1769.CrossRefPubMed Gordillo, V., del Amo, J., Soriano, V., & Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763–1769.CrossRefPubMed
Zurück zum Zitat Heckman, T. G., Anderson, E. S., Sikkema, K. J., Kochman, A., Kalichman, S. C., & Anderson, T. (2004). Emotional distress in nonmetropolitan persons living with HIV disease enrolled in a telephone-delivered coping improvement group intervention. Health Psychology, 23, 94–100.CrossRefPubMed Heckman, T. G., Anderson, E. S., Sikkema, K. J., Kochman, A., Kalichman, S. C., & Anderson, T. (2004). Emotional distress in nonmetropolitan persons living with HIV disease enrolled in a telephone-delivered coping improvement group intervention. Health Psychology, 23, 94–100.CrossRefPubMed
Zurück zum Zitat Herek, G. M., Capitanio, J. P., & Widaman, K. F. (2002). HIV-related stigma and knowledge in the United States: Prevalence and trends, 1991–1999. American Journal of Public Health, 92(3), 371–377.PubMedCrossRef Herek, G. M., Capitanio, J. P., & Widaman, K. F. (2002). HIV-related stigma and knowledge in the United States: Prevalence and trends, 1991–1999. American Journal of Public Health, 92(3), 371–377.PubMedCrossRef
Zurück zum Zitat Hoff, C. C. McKusick, L., Hillard, B., & Coates, T. J. (1992). The impact of HIV antibody status on gay men's partner preferences: A community perspective. AIDS Education and Prevention, 4, 197–204.PubMed Hoff, C. C. McKusick, L., Hillard, B., & Coates, T. J. (1992). The impact of HIV antibody status on gay men's partner preferences: A community perspective. AIDS Education and Prevention, 4, 197–204.PubMed
Zurück zum Zitat Horowitz, M., Adler, N., & Kegeles, S. (1988). A scale for measuring the occurrence of positive states of mind: A preliminary report. Psychosomatic Medicine, 50, 477–483.PubMed Horowitz, M., Adler, N., & Kegeles, S. (1988). A scale for measuring the occurrence of positive states of mind: A preliminary report. Psychosomatic Medicine, 50, 477–483.PubMed
Zurück zum Zitat Justice, A. C., Holmes, W., Gifford, A. L., Rabeneck, L., Zackin, R., Sinclair, G., et al. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54, S77–S90.CrossRefPubMed Justice, A. C., Holmes, W., Gifford, A. L., Rabeneck, L., Zackin, R., Sinclair, G., et al. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54, S77–S90.CrossRefPubMed
Zurück zum Zitat Kalichman, S. C., DiMarco, M., Austin, J., Luke, W., & DiFonzo, K. (2003). Stress, social support, and HIV-status disclosure to family and friends among HIV-positive men and women. Journal of Behavioral Medicine, 26(4), 315–332.CrossRefPubMed Kalichman, S. C., DiMarco, M., Austin, J., Luke, W., & DiFonzo, K. (2003). Stress, social support, and HIV-status disclosure to family and friends among HIV-positive men and women. Journal of Behavioral Medicine, 26(4), 315–332.CrossRefPubMed
Zurück zum Zitat Kelly, J. A., Murphy, D. A., Bahr, G. R., & Kalichman, S. C. (1993). Outcome of cognitive-behavioral and support group brief therapies for depressed, HIV-infected persons. American Journal of Psychiatry, 150, 1679–1686.PubMed Kelly, J. A., Murphy, D. A., Bahr, G. R., & Kalichman, S. C. (1993). Outcome of cognitive-behavioral and support group brief therapies for depressed, HIV-infected persons. American Journal of Psychiatry, 150, 1679–1686.PubMed
Zurück zum Zitat Klitzman, R. L., Kirschenbaum, S. B., Dodge, B., Remien, R. H., Ehrhardt, A. A., Johnson, M. O., et al. (2004). Intricacies and inter-relationships between HIV disclosure and HAART: A qualitative study. AIDS Care, 16(5), 628–640.CrossRefPubMed Klitzman, R. L., Kirschenbaum, S. B., Dodge, B., Remien, R. H., Ehrhardt, A. A., Johnson, M. O., et al. (2004). Intricacies and inter-relationships between HIV disclosure and HAART: A qualitative study. AIDS Care, 16(5), 628–640.CrossRefPubMed
Zurück zum Zitat Leserman, J., Jackson, E. D., Petitto, J. M., Golden, R. N., Silva, S. G., Perkins, D. O., et al. (1999). Progression to AIDS: The effects of stress, depressive symptoms, and social support. Psychosomatic Medicine, 61, 397–406.PubMed Leserman, J., Jackson, E. D., Petitto, J. M., Golden, R. N., Silva, S. G., Perkins, D. O., et al. (1999). Progression to AIDS: The effects of stress, depressive symptoms, and social support. Psychosomatic Medicine, 61, 397–406.PubMed
Zurück zum Zitat Malcolm, S. E., Ng, J. J., Rosen, R. K., & Stone, V. E. (2003). An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care, 15, 251–261.CrossRefPubMed Malcolm, S. E., Ng, J. J., Rosen, R. K., & Stone, V. E. (2003). An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care, 15, 251–261.CrossRefPubMed
Zurück zum Zitat Mellins, C. A., Kang, E., Cheng-Shiun, L., Havens, J. F., & Chesney, M. A. (2003). Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care and STDs, 17(8), 407–416.CrossRefPubMed Mellins, C. A., Kang, E., Cheng-Shiun, L., Havens, J. F., & Chesney, M. A. (2003). Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care and STDs, 17(8), 407–416.CrossRefPubMed
Zurück zum Zitat Mellins, C. A., Brackis-Cott, E., Dolezal, C., & Abrams, E. J. (2004). The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatric Infectious Disease Journal, 23, 1035–1041.PubMedCrossRef Mellins, C. A., Brackis-Cott, E., Dolezal, C., & Abrams, E. J. (2004). The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatric Infectious Disease Journal, 23, 1035–1041.PubMedCrossRef
Zurück zum Zitat Morse, E. V., Simon, P. M., Coburn, M., Hyslop, N., Greenspan, D., & Balson, P. M. (1991). Determinants of subject compliance within an experimental anti-HIV drug protocol. Social Science & Medicine, 10, 1161–1167.CrossRef Morse, E. V., Simon, P. M., Coburn, M., Hyslop, N., Greenspan, D., & Balson, P. M. (1991). Determinants of subject compliance within an experimental anti-HIV drug protocol. Social Science & Medicine, 10, 1161–1167.CrossRef
Zurück zum Zitat Mostashari, F., Riley, E., Selwyn, P. A., & Altice, F. L. (1998). Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immune Deficiency Syndromes, 18(4), 341–348. Mostashari, F., Riley, E., Selwyn, P. A., & Altice, F. L. (1998). Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immune Deficiency Syndromes, 18(4), 341–348.
Zurück zum Zitat Murphy, D. A., Steers, W. N., & Dello Stritto, M. E. (2001). Maternal disclosure of mother's HIV serostatus to their young children. Journal of Family Psychology, 15, 441–450.CrossRefPubMed Murphy, D. A., Steers, W. N., & Dello Stritto, M. E. (2001). Maternal disclosure of mother's HIV serostatus to their young children. Journal of Family Psychology, 15, 441–450.CrossRefPubMed
Zurück zum Zitat Murri, R., Ammassari, A., Gallicano, K., De Luca, A., Cingolani, A., Jacobson, D., et al. (2000). Patient-reported nonadherence to HAART is related to protease inhibitor levels. Journal of Acquired Immune Deficiency Syndromes, 24, 123–128.PubMed Murri, R., Ammassari, A., Gallicano, K., De Luca, A., Cingolani, A., Jacobson, D., et al. (2000). Patient-reported nonadherence to HAART is related to protease inhibitor levels. Journal of Acquired Immune Deficiency Syndromes, 24, 123–128.PubMed
Zurück zum Zitat Ouette, M., Juretzko, P., Kroidl, A., Sagir, A., Wettstein, M., Siegrist, J., et al. (2002). Lipodystrophy syndrome and self-assessment of well-being and physical appearance in HIV-positive patients. AIDS Patient Care and STDs, 16(9), 413–417.CrossRefPubMed Ouette, M., Juretzko, P., Kroidl, A., Sagir, A., Wettstein, M., Siegrist, J., et al. (2002). Lipodystrophy syndrome and self-assessment of well-being and physical appearance in HIV-positive patients. AIDS Patient Care and STDs, 16(9), 413–417.CrossRefPubMed
Zurück zum Zitat Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMed Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMed
Zurück zum Zitat Prado, G., Feaster, D. J., Schwartz, S. J., Pratt, I. A., Smith, L., & Szapocznik, J. (2004). Religious involvement, coping, social support, and psychological distress in HIV-seropositive African American mothers. AIDS and Behavior, 8, 221–235.CrossRefPubMed Prado, G., Feaster, D. J., Schwartz, S. J., Pratt, I. A., Smith, L., & Szapocznik, J. (2004). Religious involvement, coping, social support, and psychological distress in HIV-seropositive African American mothers. AIDS and Behavior, 8, 221–235.CrossRefPubMed
Zurück zum Zitat Pugatch, D., Bennett, L., & Patterson, D. (2002). HIV medication adherence in adolescents: A qualitative study. Journal of HIV/AIDS Prevention and Education for Adolescents and Children, 5(1-2), 9–29.CrossRef Pugatch, D., Bennett, L., & Patterson, D. (2002). HIV medication adherence in adolescents: A qualitative study. Journal of HIV/AIDS Prevention and Education for Adolescents and Children, 5(1-2), 9–29.CrossRef
Zurück zum Zitat Remien, R. H., Stirratt, M. J., Dolezal, C., Dognin, J. S., Wagner, G. J., Carballo-Dieguez, A., et al. (2005). Couple-focused support to improve HIV medication adherence: A randomized controlled trial. AIDS, 19, 807–814.CrossRefPubMed Remien, R. H., Stirratt, M. J., Dolezal, C., Dognin, J. S., Wagner, G. J., Carballo-Dieguez, A., et al. (2005). Couple-focused support to improve HIV medication adherence: A randomized controlled trial. AIDS, 19, 807–814.CrossRefPubMed
Zurück zum Zitat Safren, S. A., Radomsky, A. S., Otto, M. W., & Salomon, E. (2002). Predictors of psychological well-being in a diverse sample of HIV-positive patients receiving highly active antiretroviral therapy. Psychosomatics, 43, 478–485.PubMedCrossRef Safren, S. A., Radomsky, A. S., Otto, M. W., & Salomon, E. (2002). Predictors of psychological well-being in a diverse sample of HIV-positive patients receiving highly active antiretroviral therapy. Psychosomatics, 43, 478–485.PubMedCrossRef
Zurück zum Zitat Serovich, J. M. (2001). A test of two HIV disclosure theories. AIDS Education and Prevention, 13, 355–364.CrossRefPubMed Serovich, J. M. (2001). A test of two HIV disclosure theories. AIDS Education and Prevention, 13, 355–364.CrossRefPubMed
Zurück zum Zitat Siegel, K., Schrimshaw, E. W., & Raveis, V. H. (2000). Accounts for non-adherence to antiviral combination therapies among older HIV-infected adults. Psychology, Health & Medicine, 5(1), 29–42.CrossRef Siegel, K., Schrimshaw, E. W., & Raveis, V. H. (2000). Accounts for non-adherence to antiviral combination therapies among older HIV-infected adults. Psychology, Health & Medicine, 5(1), 29–42.CrossRef
Zurück zum Zitat Stirratt, M. J. (2005). I have something to tell you: HIV serostatus disclosure strategies and sexual practices. In P. N. Halkitis, C. Gomez, & R. Wolitski (Eds.), HIV+ Sex: The psychological and interpersonal dynamics of HIV-seropositive gay and bisexual men's relationships. Washington, DC: American Psychological Association. Stirratt, M. J. (2005). I have something to tell you: HIV serostatus disclosure strategies and sexual practices. In P. N. Halkitis, C. Gomez, & R. Wolitski (Eds.), HIV+ Sex: The psychological and interpersonal dynamics of HIV-seropositive gay and bisexual men's relationships. Washington, DC: American Psychological Association.
Zurück zum Zitat Swindells, S., Mohr, J., Justis, J. C., Berman, S., Squier, C., Wagener, M. M., et al. (1999). Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness. International Journal of STDs and AIDS, 10(6), 383–391.CrossRef Swindells, S., Mohr, J., Justis, J. C., Berman, S., Squier, C., Wagener, M. M., et al. (1999). Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness. International Journal of STDs and AIDS, 10(6), 383–391.CrossRef
Zurück zum Zitat Wills, T. A., & Fegan, M. F. (2001). Social networks and social support. In A. Baum, T. A. Revenson, & J. E. Singer (Eds.), Handbook of health psychology (pp. 209–234). Mahwah, NJ: Lawrence Erlbaum. Wills, T. A., & Fegan, M. F. (2001). Social networks and social support. In A. Baum, T. A. Revenson, & J. E. Singer (Eds.), Handbook of health psychology (pp. 209–234). Mahwah, NJ: Lawrence Erlbaum.
Zurück zum Zitat Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O’Shaughnessy, M. V., & Montaner, J. S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Annals of Internal Medicine, 139, 810–816.PubMed Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O’Shaughnessy, M. V., & Montaner, J. S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Annals of Internal Medicine, 139, 810–816.PubMed
Zurück zum Zitat Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O’Shaughnessy, M. V., & Montaner, J. S. (2004). The impact of adherence on CD4 cell count responses among HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 35, 261–268.PubMedCrossRef Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O’Shaughnessy, M. V., & Montaner, J. S. (2004). The impact of adherence on CD4 cell count responses among HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 35, 261–268.PubMedCrossRef
Zurück zum Zitat Zea, M. C., Reisen, C. A., Poppen, P. J., Bianchi, F. T., & Echeverry, J. J. (2005). Disclosure of HIV status and psychological well-being among Latino gay and bisexual men. AIDS & Behavior, 9, 15–26.CrossRef Zea, M. C., Reisen, C. A., Poppen, P. J., Bianchi, F. T., & Echeverry, J. J. (2005). Disclosure of HIV status and psychological well-being among Latino gay and bisexual men. AIDS & Behavior, 9, 15–26.CrossRef
Zurück zum Zitat Zierler, S., Cunningham, W. E., Andersen, R., Shapiro, M. F., Bozzette, S. A., Nakazono, T., et al. (2000). Violence victimization after HIV infection in a U.S. probability sample of adult patients in primary care. American Journal of Public Health, 90(2), 208–215.PubMed Zierler, S., Cunningham, W. E., Andersen, R., Shapiro, M. F., Bozzette, S. A., Nakazono, T., et al. (2000). Violence victimization after HIV infection in a U.S. probability sample of adult patients in primary care. American Journal of Public Health, 90(2), 208–215.PubMed
Metadaten
Titel
The Role of HIV Serostatus Disclosure in Antiretroviral Medication Adherence
verfasst von
Michael J. Stirratt
Robert H. Remien
Anna Smith
Olivia Q. Copeland
Curtis Dolezal
Daniel Krieger
the SMART Couples Study Team
Publikationsdatum
01.09.2006
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 5/2006
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-006-9106-6

Weitere Artikel der Ausgabe 5/2006

AIDS and Behavior 5/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.